Top Markets
#1 Siren Siren +34.47%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.54%
#3 Ribbita by Virtuals Ribbita by Virtuals +21.29%
#4 PulseChain PulseChain +18.23%
#5 Bitway Bitway +17.71%
#6 Cysic Cysic +17.67%
#7 KUB Coin KUB Coin +16.88%
#8 Wiki Cat Wiki Cat +16.30%
#9 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +16.06%
#10 The Grays Currency The Grays Currency +15.85%
Coin of the day
Siren Siren
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
NeuroSense Therapeutics Ltd. NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

NRSN
Classificação em ações #31164
NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical... NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyotrophic lateral sclerosis (ALS). Additionally, its early-stage research pipeline features StabiliC, a potential treatment for Parkinson's disease, and CogniC, which is under development for Alzheimer's disease. Established in 2017, NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Israel.
Preço da ação
$0.3902
Valor de mercado
$13.79M
Variação (1 dia)
-13.48%
Variação (1 ano)
-68.78%
País
IL
Negociar NeuroSense Therapeutics Ltd. (NRSN)

Categoria

Healthcare
Receita da NeuroSense Therapeutics Ltd. (NRSN)
Receita em Aug 2026 TTM: 0
De acordo com os últimos relatórios financeiros da NeuroSense Therapeutics Ltd., a receita atual da empresa (TTM) é 0. Em 2026, a empresa obteve uma receita de 0 igual a a receita do ano 2026, que foi de 0. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da NeuroSense Therapeutics Ltd. de 2026 a 2026
Receita no final de cada ano
Ano Receita Alterar
Não há dados suficientes para as datas fornecidas.
Receita de empresas similares ou concorrentes
Empresa Receita Diferença de Receita País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE